RecruitingNot applicableNCT06046131
Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.
Studying Genetic urogenital tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre Hospitalier Universitaire de la Guadeloupe
- Intervention
- Standard care(other)
- Enrollment
- 3000 target
- Eligibility
- 18 years · MALE
- Timeline
- 2023 – 2039
Study locations (2)
- CHU of Rennes, Rennes, Ille-et-Vilaine, France
- CHU of Guadeloupe, Pointe-à-Pitre, Guadeloupe, Guadeloupe
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06046131 on ClinicalTrials.govOther trials for Genetic urogenital tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT03833921Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate CancerMartha Mims
- ACTIVE NOT RECRUITINGNCT03158922The BARCODE 1 Pilot StudyInstitute of Cancer Research, United Kingdom
- ACTIVE NOT RECRUITINGPHASE1NCT00977457Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing SurgeryCity of Hope Medical Center